Literature DB >> 6200083

Abnormalities in CNS monoamine metabolism in anorexia nervosa.

W H Kaye, M H Ebert, M Raleigh, R Lake.   

Abstract

Patients with anorexia nervosa have disturbances of mood, appetite, and neuroendocrine function. Central nervous system monoamine pathways modulate these systems, and alterations in function of these systems may occur in anorexia nervosa. Because monoamine metabolism can be influenced by nutritional intake, we studied anorectics before and at intervals after correction of weight loss. Underweight anorectics had a 30% decrease in CSF homovanillic acid level and a 20% decrease in CSF 5-hydroxyindoleacetic acid concentration; these values returned to normal shortly after weight recovery. The CSF level of norepinephrine (NE) in underweight anorectics and in these patients a few weeks after weight restoration was similar to that in normal subjects. Long-term weight-recovered (20 +/- 7 months) anorectics, however, had a 50% decrease in CSF NE level compared with that of controls. Underweight anorectics have state-associated disturbances in dopamine and serotonin metabolism. Changes in NE metabolism are more complex and state independent. These abnormalities in neurotransmitter metabolism are part of the neurobiological syndrome of anorexia nervosa and may contribute to the characteristic changes in mood, behavior, and neuroendocrine function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6200083     DOI: 10.1001/archpsyc.1984.01790150040007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  38 in total

1.  Differential hemispheric involvement in anorexia nervosa.

Authors:  G Maggia; B Bianchi
Journal:  Eat Weight Disord       Date:  1998-09       Impact factor: 4.652

Review 2.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

3.  Serum brain-derived neurotrophic factor and peripheral indicators of the serotonin system in underweight and weight-recovered adolescent girls and women with anorexia nervosa.

Authors:  Stefan Ehrlich; Harriet Salbach-Andrae; Sarah Eckart; Julia V Merle; Roland Burghardt; Ernst Pfeiffer; Leonora Franke; Ralf Uebelhack; Ulrike Lehmkuhl; Rainer Hellweg
Journal:  J Psychiatry Neurosci       Date:  2009-07       Impact factor: 6.186

4.  Dopaminergic activity and exercise behavior in anorexia nervosa.

Authors:  Sasha Gorrell; Anne G E Collins; Daniel Le Grange; Tony T Yang
Journal:  OBM Neurobiol       Date:  2020-03-23

Review 5.  The role of serotonin in eating disorders.

Authors:  S F Leibowitz
Journal:  Drugs       Date:  1990       Impact factor: 9.546

6.  The 5-HTTLPR polymorphism, platelet serotonin transporter activity and platelet serotonin content in underweight and weight-recovered females with anorexia nervosa.

Authors:  Stefan Ehrlich; Leonora Franke; Susann Scherag; Roland Burghardt; Regina Schott; Nora Schneider; Simone Brockhaus; Jakob Hein; Ralf Uebelhack; Ulrike Lehmkuhl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-12-03       Impact factor: 5.270

7.  Effect of food restriction on the circadian rhythms of circulating tryptophan and serotonin in rats.

Authors:  C L Chik; A K Ho; G M Brown
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

8.  Semistarvation-induced hyperactivity compensates for decreased norepinephrine and dopamine turnover in the mediobasal hypothalamus of the rat.

Authors:  A Broocks; J Liu; K M Pirke
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 9.  Neurobiology of anorexia and bulimia nervosa.

Authors:  Walter Kaye
Journal:  Physiol Behav       Date:  2007-11-29

Review 10.  Nothing tastes as good as skinny feels: the neurobiology of anorexia nervosa.

Authors:  Walter H Kaye; Christina E Wierenga; Ursula F Bailer; Alan N Simmons; Amanda Bischoff-Grethe
Journal:  Trends Neurosci       Date:  2013-01-18       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.